Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A
- 1 May 1999
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 5 (5) , 503-511
- https://doi.org/10.1038/8385
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Characterization of Monoclonal Antibodies to Calpain 3 and Protein Expression in Muscle from Patients with Limb-Girdle Muscular Dystrophy Type 2AThe American Journal of Pathology, 1998
- γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of DystrophinThe Journal of cell biology, 1998
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic RasScience, 1997
- Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.Journal of Clinical Investigation, 1997
- Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria BlockedScience, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Juvenile limb-girdle muscular dystrophyBrain, 1996
- 30th and 31st ENMC international workshops, Naarden, The Netherlands, Held 6–8 January 1995Neuromuscular Disorders, 1995
- Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2ACell, 1995